BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

212 related articles for article (PubMed ID: 31964914)

  • 1. CRL4-Cereblon complex in Thalidomide Embryopathy: a translational investigation.
    Kowalski TW; Gomes JDA; Garcia GBC; Fraga LR; Paixao-Cortes VR; Recamonde-Mendoza M; Sanseverino MTV; Schuler-Faccini L; Vianna FSL
    Sci Rep; 2020 Jan; 10(1):851. PubMed ID: 31964914
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Genomic and in silico analyses of CRBN gene and thalidomide embryopathy in humans.
    Vianna FS; Kowalski TW; Tovo-Rodrigues L; Tagliani-Ribeiro A; Godoy BA; Fraga LR; Sanseverino MT; Hutz MH; Schuler-Faccini L
    Reprod Toxicol; 2016 Dec; 66():99-106. PubMed ID: 27751757
    [TBL] [Abstract][Full Text] [Related]  

  • 3. PLZF and its fusion proteins are pomalidomide-dependent CRBN neosubstrates.
    Shimizu N; Asatsuma-Okumura T; Yamamoto J; Yamaguchi Y; Handa H; Ito T
    Commun Biol; 2021 Nov; 4(1):1277. PubMed ID: 34764413
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Structure of the DDB1-CRBN E3 ubiquitin ligase in complex with thalidomide.
    Fischer ES; Böhm K; Lydeard JR; Yang H; Stadler MB; Cavadini S; Nagel J; Serluca F; Acker V; Lingaraju GM; Tichkule RB; Schebesta M; Forrester WC; Schirle M; Hassiepen U; Ottl J; Hild M; Beckwith RE; Harper JW; Jenkins JL; Thomä NH
    Nature; 2014 Aug; 512(7512):49-53. PubMed ID: 25043012
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Glutamine Triggers Acetylation-Dependent Degradation of Glutamine Synthetase via the Thalidomide Receptor Cereblon.
    Nguyen TV; Lee JE; Sweredoski MJ; Yang SJ; Jeon SJ; Harrison JS; Yim JH; Lee SG; Handa H; Kuhlman B; Jeong JS; Reitsma JM; Park CS; Hess S; Deshaies RJ
    Mol Cell; 2016 Mar; 61(6):809-20. PubMed ID: 26990986
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Thalidomide and its metabolite 5-hydroxythalidomide induce teratogenicity via the cereblon neosubstrate PLZF.
    Yamanaka S; Murai H; Saito D; Abe G; Tokunaga E; Iwasaki T; Takahashi H; Takeda H; Suzuki T; Shibata N; Tamura K; Sawasaki T
    EMBO J; 2021 Feb; 40(4):e105375. PubMed ID: 33470442
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Crystal structure of the SALL4-pomalidomide-cereblon-DDB1 complex.
    Matyskiela ME; Clayton T; Zheng X; Mayne C; Tran E; Carpenter A; Pagarigan B; McDonald J; Rolfe M; Hamann LG; Lu G; Chamberlain PP
    Nat Struct Mol Biol; 2020 Apr; 27(4):319-322. PubMed ID: 32251415
    [TBL] [Abstract][Full Text] [Related]  

  • 8. UBE2G1 governs the destruction of cereblon neomorphic substrates.
    Lu G; Weng S; Matyskiela M; Zheng X; Fang W; Wood S; Surka C; Mizukoshi R; Lu CC; Mendy D; Jang IS; Wang K; Marella M; Couto S; Cathers B; Carmichael J; Chamberlain P; Rolfe M
    Elife; 2018 Sep; 7():. PubMed ID: 30234487
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Thalidomide Inhibits Human iPSC Mesendoderm Differentiation by Modulating CRBN-dependent Degradation of SALL4.
    Belair DG; Lu G; Waller LE; Gustin JA; Collins ND; Kolaja KL
    Sci Rep; 2020 Feb; 10(1):2864. PubMed ID: 32071327
    [TBL] [Abstract][Full Text] [Related]  

  • 10. The CRBN, CUL4A and DDB1 Expression Predicts the Response to Immunomodulatory Drugs and Survival of Multiple Myeloma Patients.
    Barankiewicz J; Szumera-Ciećkiewicz A; Salomon-Perzyński A; Wieszczy P; Malenda A; Garbicz F; Prochorec-Sobieszek M; Misiewicz-Krzemińska I; Juszczyński P; Lech-Marańda E
    J Clin Med; 2021 Jun; 10(12):. PubMed ID: 34207079
    [TBL] [Abstract][Full Text] [Related]  

  • 11. The role of ESCO2, SALL4 and TBX5 genes in the susceptibility to thalidomide teratogenesis.
    Gomes JDA; Kowalski TW; Fraga LR; Macedo GS; Sanseverino MTV; Schuler-Faccini L; Vianna FSL
    Sci Rep; 2019 Aug; 9(1):11413. PubMed ID: 31388035
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Discovery of CRBN as a target of thalidomide: a breakthrough for progress in the development of protein degraders.
    Yamamoto J; Ito T; Yamaguchi Y; Handa H
    Chem Soc Rev; 2022 Aug; 51(15):6234-6250. PubMed ID: 35796627
    [TBL] [Abstract][Full Text] [Related]  

  • 13. New Findings in eNOS gene and Thalidomide Embryopathy Suggest pre-transcriptional effect variants as susceptibility factors.
    Kowalski TW; Fraga LR; Tovo-Rodrigues L; Sanseverino MT; Hutz MH; Schuler-Faccini L; Vianna FS
    Sci Rep; 2016 Mar; 6():23404. PubMed ID: 27004986
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Exploiting ubiquitin ligase cereblon as a target for small-molecule compounds in medicine and chemical biology.
    Ito T; Yamaguchi Y; Handa H
    Cell Chem Biol; 2021 Jul; 28(7):987-999. PubMed ID: 34033753
    [TBL] [Abstract][Full Text] [Related]  

  • 15. A novel cereblon modulator recruits GSPT1 to the CRL4(CRBN) ubiquitin ligase.
    Matyskiela ME; Lu G; Ito T; Pagarigan B; Lu CC; Miller K; Fang W; Wang NY; Nguyen D; Houston J; Carmel G; Tran T; Riley M; Nosaka L; Lander GC; Gaidarova S; Xu S; Ruchelman AL; Handa H; Carmichael J; Daniel TO; Cathers BE; Lopez-Girona A; Chamberlain PP
    Nature; 2016 Jul; 535(7611):252-7. PubMed ID: 27338790
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Structure of the human Cereblon-DDB1-lenalidomide complex reveals basis for responsiveness to thalidomide analogs.
    Chamberlain PP; Lopez-Girona A; Miller K; Carmel G; Pagarigan B; Chie-Leon B; Rychak E; Corral LG; Ren YJ; Wang M; Riley M; Delker SL; Ito T; Ando H; Mori T; Hirano Y; Handa H; Hakoshima T; Daniel TO; Cathers BE
    Nat Struct Mol Biol; 2014 Sep; 21(9):803-9. PubMed ID: 25108355
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Thalidomide embryopathy: Follow-up of cases born between 1959 and 2010.
    Kowalski TW; Sanseverino MT; Schuler-Faccini L; Vianna FS
    Birth Defects Res A Clin Mol Teratol; 2015 Sep; 103(9):794-803. PubMed ID: 26043318
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Regulation of AMPK Activity by CRBN Is Independent of the Thalidomide-CRL4
    Yang SJ; Jeon S; Baek JW; Lee KM; Park CS
    Pharmaceuticals (Basel); 2021 May; 14(6):. PubMed ID: 34073624
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Genome-wide CRISPR screens reveal genetic mediators of cereblon modulator toxicity in primary effusion lymphoma.
    Patil A; Manzano M; Gottwein E
    Blood Adv; 2019 Jul; 3(14):2105-2117. PubMed ID: 31300418
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Deciphering the mystery of thalidomide teratogenicity.
    Ito T; Handa H
    Congenit Anom (Kyoto); 2012 Mar; 52(1):1-7. PubMed ID: 22348778
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 11.